Yu Ming-Lung
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Autophagy in Disease and Therapy
Papers in
- Hepatology 374
- Hepatitis C virus research 333
- Hepatocellular Carcinoma Treatment and Prognosis 29
- Liver Disease and Transplantation 28
- Epidemiology 335
- Liver Disease Diagnosis and Treatment 250
- Hepatitis B Virus Studies 194
- Co-authors
- Wan‐Long Chuang (251 shared papers)Chia‐Yen Dai (251 shared papers)Jee‐Fu Huang (251 shared papers)Chung‐Feng Huang (202 shared papers)Zu‐Yau Lin (151 shared papers)Liang‐Yen Wang (78 shared papers)Ming‐Lun Yeh (170 shared papers)Shinn‐Cherng Chen (106 shared papers)
- Journals
- Hepatology International (39 papers)Journal of Gastroenterology and Hepatology (39 papers)Journal of Hepatology (36 papers)PLoS ONE (25 papers)Hepatology (24 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yu Ming-Lung
637 papers receiving 18.3k citations
Yu Ming-Lung's Hit Papers
Peers
Comparison fields: 5 of 168
- Hepatology 9.1k
- Epidemiology 9.4k
- Endocrinology, Diabetes and Metabolism 927
- Cancer Research 699
- Physiology 178
Countries citing papers authored by Yu Ming-Lung
This map shows the geographic impact of Yu Ming-Lung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ming-Lung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ming-Lung more than expected).
Fields of papers citing papers by Yu Ming-Lung
This network shows the impact of papers produced by Yu Ming-Lung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ming-Lung. The network helps show where Yu Ming-Lung may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Ming-Lung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 669 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Hit paper breakdown → | 2021 | 2038 |
| 2 | Advancing the global public health agenda for NAFLD: a consensus statement Hit paper breakdown → | 2021 | 600 |
| 3 | Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2023 | 362 |
| 4 | 2006 | 265 | |
| 5 | 2006 | 240 | |
| 6 | 2008 | 234 | |
| 7 | 2009 | 225 | |
| 8 | 2016 | 191 | |
| 9 | 2016 | 174 | |
| 10 | 2008 | 170 | |
| 11 | 2010 | 166 | |
| 12 | 2006 | 159 | |
| 13 | 2012 | 140 | |
| 14 | 2012 | 140 | |
| 15 | 2018 | 137 | |
| 16 | 2019 | 135 | |
| 17 | 2009 | 133 | |
| 18 | 2006 | 126 | |
| 19 | 2021 | 125 | |
| 20 | 2008 | 122 |
About Yu Ming-Lung
Yu Ming-Lung is a scholar working on Hepatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Infectious Diseases, having authored 669 papers that have together received 18.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (333 papers), Liver Disease Diagnosis and Treatment (250 papers), Hepatitis B Virus Studies (194 papers), Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease and Transplantation (28 papers), Alcohol Consumption and Health Effects (14 papers), Diet, Metabolism, and Disease (14 papers) and Systemic Lupus Erythematosus Research (13 papers). The work is most often cited by research in Hepatology (9.1k citations), Epidemiology (9.4k citations), Endocrinology, Diabetes and Metabolism (927 citations), Cancer Research (699 citations) and Physiology (178 citations). Yu Ming-Lung has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wan‐Long Chuang, Chia‐Yen Dai, Jee‐Fu Huang, Chung‐Feng Huang, Zu‐Yau Lin, Liang‐Yen Wang, Ming‐Lun Yeh, Shinn‐Cherng Chen, Ming‐Yen Hsieh and Ming‐Yuh Hsieh. Their work appears in journals such as Hepatology International, Journal of Gastroenterology and Hepatology, Journal of Hepatology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.